Low-Level Viremia in Hepatitis B Patients on Antiviral Treatment: Can We Ignore It?

被引：3
|
作者：
Min, Albert D. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Div Digest Dis, Mt Sinai Beth Israel, 10 Union Sq East,2G, New York, NY 10003 USA
来源：
HEPATOLOGY | 2017年 / 66卷 / 02期
关键词：
HEPATOCELLULAR-CARCINOMA; ENTECAVIR TREATMENT; CIRRHOSIS; RISK;
D O I：
10.1002/hep.29235
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：312 / 314
页数：3
相关论文
共 50 条
  • [21] IMPROVEMENTS OF EFFICACY AND SAFETY PROFILES OF TENOFOVIR AMIBUFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH MAINTAINED VIROLOGICAL RESPONSE OR LOW-LEVEL VIREMIA
    Liu, Zhihong
    Jin, Qinglong
    Zhang, Yuexin
    Gong, Guozhong
    Wu, Guicheng
    Yao, Lvfeng
    Wen, Xiaofeng
    Gao, Zhiliang
    Huang, Yan
    Yang, Daokun
    Chen, Enqiang
    Mao, Qing
    Lin, Shide
    Shang, Jia
    Gong, Huanyu
    Zhong, Lihua
    Yin, Huafa
    Wang, Fengmei
    Hu, Peng
    Wu, Qiong
    Pan, Chao
    Jia, Wen
    Li, Chuan
    Niu, Junqi
    Hou, Jinlin
    HEPATOLOGY, 2024, 79 (02) : E63 - E64
  • [22] New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage
    Guo-Qing Yin
    Jun Li
    Bei Zhong
    Yong-Fong Yang
    Mao-Rong Wang
    World Journal of Gastroenterology, 2021, 27 (08) : 666 - 676
  • [23] New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage
    Yin, Guo-Qing
    Li, Jun
    Zhong, Bei
    Yang, Yong-Fong
    Wang, Mao-Rong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (08) : 666 - 676
  • [24] Lamivudine is not effective in the treatment of pion-cirrhotic HBeAg (-) chronic hepatitis B patients with low level viremia
    Bozkaya, H
    Yurdaydin, C
    Bozdayi, M
    Sagiroglu, AK
    Erkan, O
    Uzunalimoglu, O
    JOURNAL OF HEPATOLOGY, 2002, 36 : 100 - 100
  • [25] Hepatitis C virus quantitation:: Optimization of strategies for detecting low-level viremia
    Hofgärtner, WT
    Kant, JA
    Weck, KE
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) : 888 - 891
  • [26] Analysis of efficacy and factors influencing sequential combination therapy with tenofovir alafenamide fumarate after treatment with entecavir in chronic hepatitis B patients with low-level viremia
    刘丽萍
    ChinaMedicalAbstracts(InternalMedicine), 2023, 40 (02) : 84 - 85
  • [27] Correlation between low-level viremia and hepatitis B-related hepatocellular carcinoma and recurrence: a retrospective study
    Sun, Furong
    Liu, Zhifei
    Wang, Bingyuan
    BMC CANCER, 2021, 21 (01)
  • [28] Correlation between low-level viremia and hepatitis B-related hepatocellular carcinoma and recurrence: a retrospective study
    Furong Sun
    Zhifei Liu
    Bingyuan Wang
    BMC Cancer, 21
  • [29] Risk factors for very low-level viremia in patients with chronic hepatitis B virus infection: A single-center retrospective study
    Lu, Jiahui
    Zhang, Congnan
    He, Pengyuan
    Ou, Mengdang
    Xia, Jinyu
    Huang, Mingxing
    LIVER RESEARCH, 2022, 6 (01) : 39 - 44
  • [30] Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia
    Paik, Namyoung
    Sinn, Dong H.
    Lee, Ji H.
    Oh, In S.
    Kim, Jung H.
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon S.
    Lee, Joon H.
    Koh, Kwang C.
    Paik, Seung W.
    LIVER INTERNATIONAL, 2018, 38 (01) : 68 - 75
12345